Atlas Trials

PRO 140 in Treatment-Experienced HIV-1 Subjects

Clinical trial NCT03902522 · COMPLETED

Trial details

NCT number
NCT03902522
Sponsor
CytoDyn, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2018-06-25
Primary completion
2020-05-18
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.